Loading clinical trials...
Loading clinical trials...
The objective of this randomized, double-blinded, placebo-controlled Phase 1 investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects wit...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Brain Neurotherapy Bio, Inc.
NCT07197866 · Multiple System Atrophy
NCT05748028 · Parkinson Disease, Multiple System Atrophy
NCT04246437 · Autonomic Failure, Pure Autonomic Failure, and more
NCT05121012 · Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)
NCT03042988 · Hypertension, Pure Autonomic Failure, and more
University of California Irvine
Irvine, California
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions